Methicillin resistance in Staphylococcus aureus
(MRSA) is a worldwide problem. The proportion of S. aureus isolates resistant to methicillin is still increasing in many parts of the world, most coun-tries now have MRSA rates of>20 % and some have rates as high as 50 % [1]. However, some countries, such as the Netherlands, Iceland and Scandinav...
| Other Authors: | |
|---|---|
| Format: | Text |
| Language: | English |
| Subjects: | |
| Online Access: | http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.488.4605 http://www.cli-online.com/uploads/tx_ttproducts/datasheet/a-test-for-the-early-detection-of-mrsaclinical-benefits-and-financial-savings.pdf |
| Summary: | (MRSA) is a worldwide problem. The proportion of S. aureus isolates resistant to methicillin is still increasing in many parts of the world, most coun-tries now have MRSA rates of>20 % and some have rates as high as 50 % [1]. However, some countries, such as the Netherlands, Iceland and Scandinavia, have still been able to maintain very low (<1%) rates of MRSA. A recent report from the European Antimicrobial Surveillance System (EARSS) illustrated how the pro-portions of MRSA vary enormously between coun-tries across Europe, from <1 % in northern Europe to>40 % in Southern and Western Europe, and with almost 100-fold difference between the lowest and highest rates observed [2]. The report also observed variations of MRSA rates between hospitals within all |
|---|